vTv Therapeutics, Inc. (VTVT)
31.18
+1.10
(+3.66%)
USD |
NASDAQ |
Oct 09, 16:00
31.06
-0.12
(-0.37%)
After-Hours: 20:00
vTv Therapeutics Price : 31.18 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 30.16 | 31.18 | 30.10 | 31.18 | 12835.00 |
| Oct 08, 2026 | 31.03 | 31.22 | 29.80 | 30.08 | 44334.00 |
| Oct 07, 2026 | 29.95 | 31.50 | 29.86 | 31.01 | 26115.00 |
| Oct 06, 2026 | 30.50 | 30.50 | 29.55 | 30.03 | 27930.00 |
| Oct 05, 2026 | 31.56 | 31.56 | 30.29 | 30.33 | 14858.00 |
| Oct 02, 2026 | 32.20 | 32.32 | 30.57 | 30.57 | 18015.00 |
| Oct 01, 2026 | 30.99 | 32.28 | 30.99 | 31.85 | 34272.00 |
| Sep 30, 2026 | 30.11 | 31.14 | 29.98 | 30.84 | 30938.00 |
| Sep 29, 2026 | 30.34 | 30.69 | 30.00 | 30.00 | 85142.00 |
| Sep 28, 2026 | 29.75 | 31.45 | 29.68 | 30.52 | 111862.0 |
| Sep 25, 2026 | 30.60 | 30.91 | 29.79 | 30.21 | 28789.00 |
| Sep 24, 2026 | 30.57 | 31.57 | 30.24 | 30.73 | 18029.00 |
| Sep 23, 2026 | 31.03 | 31.40 | 30.47 | 30.58 | 18896.00 |
| Sep 22, 2026 | 31.32 | 32.38 | 31.07 | 31.10 | 11170.00 |
| Sep 21, 2026 | 31.45 | 32.00 | 31.02 | 31.30 | 22687.00 |
| Sep 18, 2026 | 31.15 | 32.09 | 31.05 | 31.80 | 74371.00 |
| Sep 17, 2026 | 30.89 | 32.11 | 30.77 | 31.40 | 33385.00 |
| Sep 16, 2026 | 30.37 | 30.86 | 29.98 | 30.46 | 91476.00 |
| Sep 15, 2026 | 31.30 | 31.90 | 29.76 | 30.46 | 45336.00 |
| Sep 14, 2026 | 31.80 | 32.53 | 31.44 | 31.44 | 22152.00 |
| Sep 11, 2026 | 32.24 | 32.54 | 31.29 | 31.97 | 13723.00 |
| Sep 10, 2026 | 33.00 | 33.00 | 31.85 | 31.86 | 46338.00 |
| Sep 09, 2026 | 32.99 | 34.14 | 32.78 | 33.29 | 39543.00 |
| Sep 08, 2026 | 33.35 | 33.38 | 32.48 | 32.79 | 28071.00 |
| Sep 04, 2026 | 32.97 | 33.72 | 32.97 | 33.35 | 12065.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
| Anika Therapeutics, Inc. | 19.58 |
| Savara, Inc. | 4.92 |
| Vericel Corp. | 40.10 |
Price Related Metrics
| PS Ratio | 10.05 |
| Price to Book Value | 1.562 |
| Earnings Yield | -3.39% |
| Market Cap | 122.81M |